Somente para uso analítico e de pesquisa — não destinado ao consumo humano ou veterinário.
Descrição
Visão geral
Lamivudine EP Impurity F, Lamivudine, 66-22-8, 1H-pyrimidine-2,4-dione
A Anant Labs é a renomada e autêntica fabricante e fornecedora de Lamivudine EP Impurity F na Índia.
A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.
Sinônimos
Lamivudine Impurity Furacil66-22-8pyrimidine-2,4(1H,3H)-dione2,4(1H,3H)-PyrimidinedionePyrodHybar X2,4-DioxopyrimidinePirod2,4-Pyrimidinedione1H-Pyrimidine-2,4-dione1,2,3,4-tetrahydropyrimidine-2,4-dioneNSC-3970DTXSID4021424SQ-6201SQ-7726SQ-8493CHEBI:17568BMS-205603-0156HH86ZVCTNSC3970DTXCID1014242, 4-DioxopyrimidineRefChem:63382-hydroxy-4-(1H)-pyrimidione2-hydroxy-4-(3H)-pyrimidione4-hydroxy-2-(1H)-pyrimidione200-621-92,4-Dihydroxypyrimidinepyrimidine-2,4-diol2,4-Pyrimidinediol51953-14-1Uracil [USAN]RU 12709MFCD000060162-Hydroxy-4(3H)-pyrimidinoneNSC 3970Ura2,4-Pyrimidinediol (9CI)CCRIS 30772-Hydroxy-4(1H)-pyrimidinoneSQ 6201SQ 7726SQ 8493BMS 205603-01AI3-25470Lamivudine impurity e4-Hydroxy-2(1H)-pyrimidinone66255-05-8Lamivudine impurity e rsFluorouracil specified compound c144104-68-7NCGC00181030-014-HydroxyuracilCAS-66-22-8Pyrimidine-2,4(1H,3H)-dione (Uracil)Uracil (8CI)Uracil [USAN:JAN]2(1H)-Pyrimidinone, 4-hydroxy-2(1H)-Pyrimidinone, 6-hydroxy-4(3H)-Pyrimidinone, 2-hydroxy-EINECS 200-621-9UNII-56HH86ZVCTUracylUrazil66224-60-08h-uracilhydroxypyrimidinoneUracil (Standard)2,6-Dioxypyrimidin2,4-Dioxypyrimidine2,4(1H,3H)-Pyrimidinedione (9CI)pyrimidine-2,4-dioneUracil, 99%1ui0Uracil (JAN/USAN)2,3H)-Pyrimidinedione2,6-DihydroxypyrimidineURACIL [JAN]URACIL [USP-RS]URACIL [WHO-DD]Lamivudine EP Impurity FURACIL [MI]URACIL [MART.]bmse000187bmse000940CHEMBL566Epitope ID:120356NCIMech_000782SCHEMBL8235Fluorouracil impurity C CRSUracil, >=99.0%pyrimidine, 2,4-dihydroxy-SCHEMBL29730SCHEMBL80962SCHEMBL9431051953-19-6MLS001304993SCHEMBL144010SCHEMBL151239SCHEMBL537174SCHEMBL877869SCHEMBL925137GTPL4560orb1310972SCHEMBL1050479SCHEMBL5089507SCHEMBL6286831SCHEMBL6434097SCHEMBL6434098SCHEMBL7267501SCHEMBL7335265SCHEMBL9734266SCHEMBL97797872,4-(1h,3h)-pyrimidinedioneSCHEMBL10580164SCHEMBL11607890SCHEMBL13276278SCHEMBL29525634SCHEMBL31434533HY-I0960RUracil, >=99.0% (T)1,3-dihydropyrimidine-2,4-dioneHMS2234E19HMS3264C13HMS3373E18HMS3652N05HMS5082D06Pharmakon1600-015023454(1H)-Pyrimidinone, 2-hydroxy-HY-I0960NSC29742ZAA89752Tox21_112680Tox21_201023BDBM50549809CCG-35866EBC-13197MSK000882NSC-29742NSC759649s4177SBB058492STK301734STL124066AKOS000119989AKOS002303991Tox21_112680_1CCG-213042CS-W020104DB03419FU01843NSC-759649PS-5279SB55489SB55884NCGC00181030-02NCGC00247663-01NCGC00258576-01Uracil, Vetec(TM) reagent grade, 98%NCI60_003718SMR000752912SY008943DB-030518DB-103964DB-268940DB-268966DB-272084DB-272202LAMIVUDINE IMPURITY F [EP IMPURITY]FLUOROURACIL IMPURITY C [EP IMPURITY]LAMIVUDINE IMPURITY E [USP IMPURITY]NS00002070ST45061548SW220239-1U0013EN300-17138Uracil, suitable for cell culture, BioReagentC00106D00027SBI-0053640.0002AB00171810_03AB00171810_04AB00918623-05AC-907/30002021F036407Q182990BRD-K80129304-001-08-1BRD-K80129304-001-09-9Z56889474F1796-0008FLUOROURACIL SPECIFIED COMPOUND C [USP IMPURITY]E2FC11E5-1887-46DF-B415-82313CE9B2BDUracil, United States Pharmacopeia (USP) Reference StandardUracil; Lamivudine EP Impurity F; Fluorouracil EP Impurity C2,4(1H,3H)-Pyrimidinedione; 2,4-Dihydroxypyrimidine; 2,4-PyrimidinediolFluorouracil impurity C, European Pharmacopoeia (EP) Reference StandardInChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8Uracil, Pharmaceutical Secondary Standard; Certified Reference Material
